Monoclonal antibody targeting of IL-3 receptor α with CSL362 effectively depletes CML progenitor and stem cells.

Abstract:

:Despite the remarkable efficacy of tyrosine kinase inhibitors (TKIs) in eliminating differentiated chronic myeloid leukemia (CML) cells, recent evidence suggests that leukemic stem and progenitor cells (LSPCs) persist long term, which may be partly attributable to cytokine-mediated resistance. We evaluated the expression of the interleukin 3 (IL-3) receptor α subunit (CD123), an established marker of acute myeloid leukemia stem cells, on CML LSPCs and the potential of targeting those cells with the humanized anti-CD123 monoclonal antibody CSL362. Compared with normal donors, CD123 expression was higher in CD34(+)/CD38(-) cells of both chronic phase and blast crisis CML patients, with levels increasing upon disease progression. CSL362 effectively targeted CML LSPCs by selective antibody-dependent cell-mediated cytotoxicity (ADCC)-facilitated lysis of CD123(+) cells and reduced leukemic engraftment in mice. Importantly, not only were healthy donor allogeneic natural killer (NK) cells able to mount an effective CSL362-mediated ADCC response, but so were CML patients' autologous NK cells. In addition, CSL362 also neutralized IL-3-mediated rescue of TKI-induced cell death. Notably, combination of TKI- and CSL362-induced ADCC caused even greater reduction of CML progenitors and further augmented their preferential elimination over normal hematopoietic stem and progenitor cells. Thus, our data support the further evaluation of CSL362 therapy in CML.

journal_name

Blood

journal_title

Blood

authors

Nievergall E,Ramshaw HS,Yong AS,Biondo M,Busfield SJ,Vairo G,Lopez AF,Hughes TP,White DL,Hiwase DK

doi

10.1182/blood-2012-12-475194

subject

Has Abstract

pub_date

2014-02-20 00:00:00

pages

1218-28

issue

8

eissn

0006-4971

issn

1528-0020

pii

blood-2012-12-475194

journal_volume

123

pub_type

杂志文章

相关文献

BLOOD文献大全
  • Inactivation of purified human alpha 2-antiplasmin and purified human C1 inhibitor by synthetic fibrinolytic agents.

    abstract::3-Hydroxypropyl flufenamide (Flu-HPA) is one of a series of flufenamic acid derivatives that enhances blood clot lysis in vitro. Studies of possible mechanisms of action of Flu-HPA were undertaken. The profibrinolytic activity of Flu-HPA in clot lysis assays was found to be dependent on plasminogen. The influence of F...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Miles LA,Burnier JP,Verlander MS,Goodman M,Kleiss AJ,Griffin JH

    更新日期:1981-06-01 00:00:00

  • Congenital afibrinogenemia: first identification of splicing mutations in the fibrinogen Bbeta-chain gene causing activation of cryptic splice sites.

    abstract::Congenital afibrinogenemia is a rare inherited coagulopathy, characterized by very low or unmeasurable plasma levels of immunoreactive fibrinogen. So far, 25 mutations have been identified in afibrinogenemia, 17 in the Aalpha, 6 in the gamma, and only 2 in the Bbeta fibrinogen-chain genes. Here, 2 afibrinogenemic prob...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2002-06-1647

    authors: Spena S,Duga S,Asselta R,Malcovati M,Peyvandi F,Tenchini ML

    更新日期:2002-12-15 00:00:00

  • Tracing the development of acute myeloid leukemia in CBL syndrome.

    abstract::We describe the development of acute myeloid leukemia (AML) in an adult with CBL syndrome caused by a heterozygous de novo germline mutation in CBL codon D390. In the AML bone marrow, the mutated CBL allele was homozygous after copy number-neutral loss-of-heterozygosity and amplified through a chromosomal gain; moreov...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2013-10-533844

    authors: Becker H,Yoshida K,Blagitko-Dorfs N,Claus R,Pantic M,Abdelkarim M,Niemöller C,Greil C,Hackanson B,Shiraishi Y,Chiba K,Tanaka H,Miyano S,Döhner K,Schnittger S,Henneke P,Niemeyer CM,Flotho C,Pfeifer D,Ogawa S,Lübber

    更新日期:2014-03-20 00:00:00

  • c-Jun N-terminal kinase (JNK) is required for survival and proliferation of B-lymphoma cells.

    abstract::Several primary murine and human B lymphomas and cell lines were found to constitutively express high levels of the activated form of c-jun N-terminal kinase (JNK), a member of the mitogen-activated protein (MAP) kinase family. Proliferation of murine B lymphomas CH31, CH12.Lx, BKS-2, and WEHI-231 and the human B lymp...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2004-10-3819

    authors: Gururajan M,Chui R,Karuppannan AK,Ke J,Jennings CD,Bondada S

    更新日期:2005-08-15 00:00:00

  • 2',5'-Oligoadenylate-antisense chimeras cause RNase L to selectively degrade bcr/abl mRNA in chronic myelogenous leukemia cells.

    abstract::We report an RNA targeting strategy, which selectively degrades bcr/abl mRNA in chronic myelogenous leukemia (CML) cells. A 2', 5'-tetraadenylate activator (2-5A) of RNase L was chemically linked to oligonucleotide antisense directed against either the fusion site or against the translation start sequence in bcr/abl m...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Maran A,Waller CF,Paranjape JM,Li G,Xiao W,Zhang K,Kalaycio ME,Maitra RK,Lichtin AE,Brugger W,Torrence PF,Silverman RH

    更新日期:1998-12-01 00:00:00

  • Caveolin-1 regulates TCR signal strength and regulatory T-cell differentiation into alloreactive T cells.

    abstract::Caveolin-1 (Cav-1) is a key organizer of membrane specializations and a scaffold protein that regulates signaling in multiple cell types. We found increased Cav-1 expression in human and murine T cells after allogeneic hematopoietic cell transplantation. Indeed, Cav-1(-/-)donor T cells caused less severe acute graft-v...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2015-09-672428

    authors: Schönle A,Hartl FA,Mentzel J,Nöltner T,Rauch KS,Prestipino A,Wohlfeil SA,Apostolova P,Hechinger AK,Melchinger W,Fehrenbach K,Guadamillas MC,Follo M,Prinz G,Ruess AK,Pfeifer D,del Pozo MA,Schmitt-Graeff A,Duyster J,H

    更新日期:2016-04-14 00:00:00

  • Successful treatment of pure red cell aplasia with rituximab in patients with chronic lymphocytic leukemia.

    abstract::Pure red cell aplasia (PRCA) is a rare complication in patients with chronic lymphocytic leukemia (CLL). It is characterized by reticulocytopenia and by an absence of red cell precursors in the bone marrow. Unlike autoimmune hemolytic anemia, which is characterized by an increased number of reticulocytes, positive Coo...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v99.3.1092

    authors: Ghazal H

    更新日期:2002-02-01 00:00:00

  • Stem cell exhaustion due to Runx1 deficiency is prevented by Evi5 activation in leukemogenesis.

    abstract::The RUNX1/AML1 gene is the most frequently mutated gene in human leukemia. Conditional deletion of Runx1 in adult mice results in an increase of hematopoietic stem cells (HSCs), which serve as target cells for leukemia; however, Runx1(-/-) mice do not develop spontaneous leukemia. Here we show that maintenance of Runx...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2009-07-232249

    authors: Jacob B,Osato M,Yamashita N,Wang CQ,Taniuchi I,Littman DR,Asou N,Ito Y

    更新日期:2010-02-25 00:00:00

  • NBS1 is required for macrophage homeostasis and functional activity in mice.

    abstract::Nijmegen breakage syndrome 1 (NBS1) is a component of the MRE11 complex, which is a sensor of DNA double-strand breaks and plays a crucial role in the DNA damage response. Because activated macrophages produce large amounts of reactive oxygen species (ROS) that can cause DNA lesions, we examined the role of NBS1 in ma...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2015-04-637371

    authors: Pereira-Lopes S,Tur J,Calatayud-Subias JA,Lloberas J,Stracker TH,Celada A

    更新日期:2015-11-26 00:00:00

  • Animal model of fetal and neonatal immune thrombocytopenia: role of neonatal Fc receptor in the pathogenesis and therapy.

    abstract::Fetal and neonatal immune thrombocytopenia (FNIT) is a severe bleeding disorder in which maternal antibodies cross the placenta and destroy fetal/neonatal platelets. It has been demonstrated that the neonatal Fc receptor (FcRn) regulates immunoglobulin G (IgG) homeostasis and plays an important role in transplacental ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-05-284919

    authors: Chen P,Li C,Lang S,Zhu G,Reheman A,Spring CM,Freedman J,Ni H

    更新日期:2010-11-04 00:00:00

  • IL-13 production by donor T cells is prognostic of acute graft-versus-host disease following unrelated donor stem cell transplantation.

    abstract::Despite the success of human leukocyte antigen (HLA) typing in allogeneic stem cell transplantation (SCT) it is rare to find an unrelated donor that is perfectly matched, making identification of "permissive" mismatches of paramount importance. Here, we describe novel associations between donor T-cell cytokine product...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-01-0192

    authors: Jordan WJ,Brookes PA,Szydlo RM,Goldman JM,Lechler RI,Ritter MA

    更新日期:2004-01-15 00:00:00

  • Antimyeloperoxidase antibodies rapidly induce alpha-4-integrin-dependent glomerular neutrophil adhesion.

    abstract::Patients with antineutrophil cytoplasmic antibodies (ANCAs) frequently develop severe vasculitis and glomerulonephritis. Although ANCAs, particularly antimyeloperoxidase (anti-MPO), have been shown to promote leukocyte adhesion in postcapillary venules, their ability to promote adhesion in the glomerular vasculature i...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2008-12-192617

    authors: Kuligowski MP,Kwan RY,Lo C,Wong C,James WG,Bourges D,Ooi JD,Abeynaike LD,Hall P,Kitching AR,Hickey MJ

    更新日期:2009-06-18 00:00:00

  • The future of anti-CD20 monoclonal antibodies: are we making progress?

    abstract::The anti-CD20 monoclonal antibody (mAb) rituximab has revolutionized the treatment of B-cell malignancies. This unprecedented success has not only substantially changed the mindset of the clinical community about the ability of mAb to improve outcomes but has catalyzed the interest in the pharmaceutical industry to de...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-07-298356

    authors: Alduaij W,Illidge TM

    更新日期:2011-03-17 00:00:00

  • Virus-specific T-cell therapies for patients with primary immune deficiency.

    abstract::Viral infections are common and are potentially life-threatening in patients with moderate to severe primary immunodeficiency disorders. Because T-cell immunity contributes to the control of many viral pathogens, adoptive immunotherapy with virus-specific T cells (VSTs) has been a logical and effective way of combatin...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood.2019000924

    authors: Keller MD,Bollard CM

    更新日期:2020-02-27 00:00:00

  • Leukemia secondary to myeloproliferative neoplasms.

    abstract::Secondary acute myeloid leukemias (AMLs) evolving from an antecedent myeloproliferative neoplasm (MPN) are characterized by a unique set of cytogenetic and molecular features distinct from de novo AML. Given the high frequency of poor-risk cytogenetic and molecular features, malignant clones are frequently insensitive...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2019000943

    authors: Dunbar AJ,Rampal RK,Levine R

    更新日期:2020-07-02 00:00:00

  • A PAR domain transcription factor is involved in the expression from a hematopoietic-specific promoter for the human LMO2 gene.

    abstract::The transcription factor LMO2 is believed to exert its effect through the formation of protein-protein interactions with other DNA-binding factors such as GATA-1 and TAL1. Although LMO2 has been shown to be critical for the formation of the erythroid cell lineage, the gene is also expressed in a number of nonerythroid...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2002-09-2702

    authors: Crable SC,Anderson KP

    更新日期:2003-06-15 00:00:00

  • Platelet adhesion to fibronectin in flow: the importance of von Willebrand factor and glycoprotein Ib.

    abstract::We describe glycoprotein (GP) Ib as a mediator of adhesion to fibronectin, specifically in flow. A monoclonal antibody (MoAb) directed to the von Willebrand factor (vWF)-binding site on this receptor or the absence of this receptor on the platelet membrane, in the case of a patient with the Bernard-Soulier syndrome, r...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Beumer S,Heijnen HF,IJsseldijk MJ,Orlando E,de Groot PG,Sixma JJ

    更新日期:1995-11-01 00:00:00

  • Somatic FAS mutations are common in patients with genetically undefined autoimmune lymphoproliferative syndrome.

    abstract::Autoimmune lymphoproliferative syndrome (ALPS) is characterized by childhood onset of lymphadenopathy, hepatosplenomegaly, autoimmune cytopenias, elevated numbers of double-negative T (DNT) cells, and increased risk of lymphoma. Most cases of ALPS are associated with germline mutations of the FAS gene (type Ia), where...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-01-263145

    authors: Dowdell KC,Niemela JE,Price S,Davis J,Hornung RL,Oliveira JB,Puck JM,Jaffe ES,Pittaluga S,Cohen JI,Fleisher TA,Rao VK

    更新日期:2010-06-24 00:00:00

  • Thrombopoietin, but not erythropoietin, directly stimulates multilineage growth of primitive murine bone marrow progenitor cells in synergy with early acting cytokines: distinct interactions with the ligands for c-kit and FLT3.

    abstract::Thrombopoietin (Tpo), the ligand for c-mpl, has been shown to be the principal regulator of megakaryocytopoiesis and platelet production. The ability of Tpo to potently stimulate the growth of committed megakaryocyte (Mk) progenitor cells has been studied in detail. Murine fetal liver cells, highly enriched in primiti...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Ramsfjell V,Borge OJ,Veiby OP,Cardier J,Murphy MJ Jr,Lyman SD,Lok S,Jacobsen SE

    更新日期:1996-12-15 00:00:00

  • Free radical stress in chronic lymphocytic leukemia cells and its role in cellular sensitivity to ROS-generating anticancer agents.

    abstract::2-Methoxyestradiol (2-ME), a new anticancer agent currently in clinical trials, has been demonstrated to inhibit superoxide dismutase (SOD) and to induce apoptosis in leukemia cells through a free radical-mediated mechanism. Because the accumulation of superoxide (O(2)-) by inhibition of SOD depends on the cellular ge...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2002-08-2512

    authors: Zhou Y,Hileman EO,Plunkett W,Keating MJ,Huang P

    更新日期:2003-05-15 00:00:00

  • A thrombolytic regimen for high-risk deep venous thrombosis may substantially reduce the risk of postthrombotic syndrome in children.

    abstract::Important predictors of adverse outcomes of thrombosis in children, including postthrombotic syndrome (PTS), have recently been identified. Given this knowledge and the encouraging preliminary pediatric experience with systemic thrombolysis, we sought to retrospectively analyze our institutional experience with a thro...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2006-12-061234

    authors: Goldenberg NA,Durham JD,Knapp-Clevenger R,Manco-Johnson MJ

    更新日期:2007-07-01 00:00:00

  • A20 protects endothelial cells from TNF-, Fas-, and NK-mediated cell death by inhibiting caspase 8 activation.

    abstract::A20 is a stress response gene in endothelial cells (ECs). A20 serves a dual cytoprotective function, protecting from tumor necrosis factor (TNF)-mediated apoptosis and inhibiting inflammation via blockade of the transcription factor nuclear factor-kappaB (NF-kappaB). In this study, we evaluated the molecular basis of ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-02-0635

    authors: Daniel S,Arvelo MB,Patel VI,Longo CR,Shrikhande G,Shukri T,Mahiou J,Sun DW,Mottley C,Grey ST,Ferran C

    更新日期:2004-10-15 00:00:00

  • Partial immune reconstitution of X-linked hyper IgM syndrome with recombinant CD40 ligand.

    abstract::X-linked hyper IgM syndrome (XHM) is a combined immune deficiency disorder caused by genetic alterations in CD40 ligand. The purpose of this study was to investigate the safety and efficacy of recombinant CD40 ligand (rCD40L) in the treatment of the disease. Three children were administered rCD40L subcutaneously 3 tim...

    journal_title:Blood

    pub_type: 临床试验,杂志文章

    doi:10.1182/blood-2011-04-351254

    authors: Jain A,Kovacs JA,Nelson DL,Migueles SA,Pittaluga S,Fanslow W,Fan X,Wong DW,Massey J,Hornung R,Brown MR,Spinner JJ,Liu S,Davey V,Hill HA,Ochs H,Fleisher TA

    更新日期:2011-10-06 00:00:00

  • Antihuman plasma glutathione peroxidase antibodies: immunologic investigations to determine plasma glutathione peroxidase protein and selenium content in plasma.

    abstract::Plasma glutathione peroxidase (GSHPx) (glutathione: H2O2 oxidoreductase) is a unique selenoglycoprotein. Treatment of this enzyme with glycopeptidase F partially deglycosylates it and establishes the presence of N-linked sugar moieties. Antibodies raised in a rabbit against the purified enzyme from plasma were found t...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Avissar N,Whitin JC,Allen PZ,Palmer IS,Cohen HJ

    更新日期:1989-01-01 00:00:00

  • Transfusion-related sepsis: a silent epidemic.

    abstract::In this issue of Blood, Hong et al advocate for use of additional US Food and Drug Administration (FDA)–approved safety measures for transfusion. Most patients transfused with contaminated platelets do not show immediate clinical signs. Active surveillance suggests patient risk 10- to 40-fold higher than passive hemov...

    journal_title:Blood

    pub_type: 评论,杂志文章

    doi:10.1182/blood-2015-12-685198

    authors: Benjamin RJ

    更新日期:2016-01-28 00:00:00

  • GILZ, a new target for the transcription factor FoxO3, protects T lymphocytes from interleukin-2 withdrawal-induced apoptosis.

    abstract::Interleukin-2 (IL-2) withdrawal is a physiologic process inducing cell death in activated T lymphocytes. Glucocorticoid-induced leucine zipper (GILZ) has recently been identified as a protein modulating T-cell receptor activation by repressing various signaling pathways. We report here that IL-2 deprivation leads to e...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-12-4295

    authors: Asselin-Labat ML,David M,Biola-Vidamment A,Lecoeuche D,Zennaro MC,Bertoglio J,Pallardy M

    更新日期:2004-07-01 00:00:00

  • Aberrant expression of B-lymphocyte stimulator by B chronic lymphocytic leukemia cells: a mechanism for survival.

    abstract::B-cell chronic lymphocytic leukemia (B-CLL) is defined by the accumulation of CD5(+) B cells in the periphery and bone marrow. This disease is not characterized by highly proliferative cells but rather by the presence of leukemic cells with significant resistance to apoptosis and, therefore, prolonged survival. B-lymp...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2002-02-0558

    authors: Novak AJ,Bram RJ,Kay NE,Jelinek DF

    更新日期:2002-10-15 00:00:00

  • Expression of myelomonocytic antigens on chronic lymphocytic leukemia B cells correlates with their ability to produce interleukin 1.

    abstract::We analyzed the expression of myelomonocytic-associated antigens on lymphocytes from B cell chronic lymphocytic leukemia (B-CLL) patients. Blood mononuclear cells were depleted of monocytes by one-step Percoll density gradient centrifugation and tested for antigen expression by fluorescent microscopy and flow cytometr...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Morabito F,Prasthofer EF,Dunlap NE,Grossi CE,Tilden AB

    更新日期:1987-12-01 00:00:00

  • Studies on the basis for the properties of fibrin produced from fibrinogen-containing gamma' chains.

    abstract::Human fibrinogen 1 is homodimeric with respect to its gamma chains (gammaA-gammaA'), whereas fibrinogen 2 molecules each contain one gammaA (gammaA1-411V) and one gamma' chain, which differ by containing a unique C-terminal sequence from gamma'408 to 427L that binds thrombin and factor XIII. We investigated the struct...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2005-01-0240

    authors: Siebenlist KR,Mosesson MW,Hernandez I,Bush LA,Di Cera E,Shainoff JR,Di Orio JP,Stojanovic L

    更新日期:2005-10-15 00:00:00

  • Gamma (immune) interferon production by leukocytes from a patient with a TG cell proliferative disease.

    abstract::We report a patient with a disease characterized by proliferation of T cells with Fc receptors for IgG (TG). However, unlike lymphoid cells from normal individuals or from patients with other lymphoid malignancies, the patient's lymphocytes spontaneously produced gamma interferon (IFN-gamma) in vitro. The peripheral l...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Hooks JJ,Haynes BF,Detrick-Hooks B,Diehl LF,Gerrard TL,Fauci AS

    更新日期:1982-01-01 00:00:00